Comparison Study of Lidocaine and Lidocaine combined with Metoclopramide for Decreased Episiotomy Wound Pain due to Vaginal Delivery : Randomized controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200719003

Enrollment

280

Registered

2020-07-19

Start date

2020-07-17

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain score lidocaine combined with metoclopramide

Interventions

1%lidocaine 10ml injected subcutaneous before episiotomy wound repaired,1% lidocaine 10ml combined with metoclopramide (10mg/2ml )2ml

Active Comparator Drug,Experimental Drug

1%lidocaine 10ml,1%liocaine combined with metoclopramide

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.normal delivery at Bhumibol adulyadej hospital 2.term pregnancy 3.no antenatal complication 4.episiotomy wound grade2 5.consent to be a participant 6.can communication with Thai language 7age â‰¥18 years

Exclusion criteria

Exclusion criteria: 1.operative vaginal delivery 2.allergy /side effect to Lidocaine or Metoclopramide 3.episiotomy wound grade 3-4

Design outcomes

Primary

Measure	Time frame
Pain score Immediately , 2hr ,4hr , 6hr after episiotomy wound repair Pain score 0-10	—

Secondary

Measure	Time frame
Analgesic drug requirement when episiotomy wound repaired Amount of lidocaine that add on when episiotomy wound repaired	—

Countries

Thailand

Contacts

Public ContactNutthayaporn Kameesak

Bhumibol adulyadej hospital

evening_night@hotmail.com083-2943184

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026